glp-1 drugs cost How do prices of for weight loss in the U.S. compare to peer nations' prices? GLP-1 Agonists Weight Loss Drugs
Description
Carter, PharmD Medical Reviewer Kristina D
Makino H, Nakamura Y, Wada J
Adusumalli, Racial, Ethnic, and Socioeconomic Inequities in Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Diabetes in the US
Harasta et al., 2015
Here is a nice comparison table and some nuggets to think about
According to Schneider, Nestl Health Science already has more than 1.5 billion Swiss francs of revenue from products that provide nutritional benefits suitable to GLP-1 patients
